Skip to main content
Caplight Logo









Keyhole Therapeutics

Keyhole Therapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://keyholetherapeutics.com

Company Overview

Keyhole Therapeutics is a biotechnology company that develops first-in-class immunotherapies for cancer and autoimmune diseases by targeting exosome-mediated immune suppression.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryimmunotherapyexosomesmall molecule inhibitorcancer researchautoimmune diseasepreclinical drugimmune checkpoint inhibitorbiotech startupimmuno-oncologydrug pipelinetherapeutic developmentev inhibitorbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Keyhole Therapeutics Comparables

Compare Keyhole Therapeutics with similar companies based on industry and business-model similarity.

Keyhole Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EV Therapeutics
80%
Aluda Pharmaceuticals
74%
Relay Therapeutics
65%

Keyhole Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Keyhole Therapeutics Filings

Explore SEC and related filing metadata, where available.

Keyhole Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Keyhole Therapeutics's valuation, stock price, and market status.

Is Keyhole Therapeutics a public or private company?

Keyhole Therapeutics is a private company.

What is the current stock price of Keyhole Therapeutics?

Keyhole Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Keyhole Therapeutics worth (valuation)?

Valuation information for Keyhole Therapeutics is not publicly available.

Can I buy Keyhole Therapeutics stock?

Keyhole Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Keyhole Therapeutics's last funding round?

Funding round information for Keyhole Therapeutics is not publicly available.

Who are the main investors in Keyhole Therapeutics?

Investor information for Keyhole Therapeutics is not publicly disclosed.

Will Keyhole Therapeutics IPO soon?

No public IPO plans have been announced for Keyhole Therapeutics.

How can I track Keyhole Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Keyhole Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?